The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated.
Gottschalk Ar , Quintáns J , Thompson Cb , Boise Lh
Cell Death & Differentiation 3 ( 1) 113 -118
17
1996
Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
Westin Eh , Boise Lh , Gorse Km
Oncogene 7 ( 9) 1817 -1825
14
1992
The apoptosis-associated gamma-ray response of BCL-X(L) depends on normal p53 function.
Fornace Aj , Alamo I , Zhan Q , Boise Lh
Oncogene 13 ( 10) 2287 -2293
63
1996
Azidothymidine and Interferon-α Induce Apoptosis in Herpesvirus-associated Lymphomas
Eckhard Podack , Vadim Deyev , Richard K. Lee , Wenle Xia
Cancer Research 59 ( 21) 5514 -5520
51
1999
Kaposi's sarcoma tumor cells preferentially express Bcl-XL
Brian J. Nickoloff , Brian J. Nickoloff , Peter J. Polverini , Gabriel Nunez
American Journal of Pathology 149 ( 3) 795 -803
68
1996
R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathways.
Mathias G. Lichtenheld , Darrin M. Beaupre , Enrique Cepero , Lawrence H. Boise
Molecular Cancer Therapeutics 3 ( 2) 179 -186
51
2004
Overexpression of Bcl-XL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation.
Ralph Weichselbaum , Donald Kufe , Rakesh Datta , Neelam Taneja
Cell Growth & Differentiation 6 ( 4) 363 -370
127
1995
Feasibility and Correlates of Arsenic Trioxide Combined with Ascorbic Acid-mediated Depletion of Intracellular Glutathione for the Treatment of Relapsed/Refractory Multiple Myeloma
Jennifer McCafferty-Grad , Hugo F. Fernandez , Isildinha Reis , Mark Goodman
Clinical Cancer Research 8 ( 12) 3658 -3668
231
2002
Altered expression of cell cycle related genes including c-myb in a subclone of HL-60 that exhibits reversible differentiation.
Eric H. Westin , Steven Grant , Lawrence H. Boise
Cell Growth & Differentiation 3 ( 1) 53 -61
11
1992
Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells.
Jennifer McCafferty-Grad , Nancy Krett , Isildinha Reis , Nizar J. Bahlis
Molecular Cancer Therapeutics 2 ( 11) 1155 -1164
60
2003
Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons.
Vytautas P. Bindokas , Ghanashyam D. Ghadge , Jochen H M Prehn , Richard J. Miller
Molecular Pharmacology 49 ( 2) 319 -328
169
1996
Pillars Article: CD28 Costimulation Can Promote T Cell Survival by Enhancing the Expression of Bcl-xL. Immunity. 1995. 3: 87–98
Carl H. June , Mary Ann Accavitti , Andy J. Minn , Tullia Lindsten
Journal of Immunology 185 ( 7) 3788 -3799
62
2010
Lenalidomide, Bortezomib, and Dexamethasone (RVD) As Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)
Sagar Lonial , Leonard Heffner , Charise Gleason , Jonathan L. Kaufman
Blood 130 3139 -3139
2017
Protein Homeostasis: A Key Target in Myeloma
Lawrence H. Boise
Blood 130
2017
Predicting Venetoclax Sensitivity in Multiple Myeloma Using Biologic Activity Assays
Shannon Matulis , Sagar Lonial , Jonathan L. Kaufman , Ajay Nooka
Blood 130 3056 -3056
2017
Clinical Characteristics and Outcomes of Myeloma Patients Exhibiting Translocation (14;16): An Ultra-High-Risk Group of Myeloma Patients
Efstathios Kastritis , David L. Jaye , Maria Roussou , Sagar Lonial
Blood 130 1822 -1822
2017
Phase 1 Study of Venetoclax in Combination with Dexamethasone As Targeted Therapy for t(11;14) Relapsed/Refractory Multiple Myeloma
Joseph Mikhael , Thierry Facon , Ravi Vij , Cristina J. Gasparetto
Blood 130 3131 -3131
9
2017
Single Cell Resolution Profiling Defines the Innate and Adaptive Immune Repertoires Modulated By Daratumumab and IMiDs Treatment in Multiple Myeloma (MM)
Anjan Thakurta , Victor Jimenez-Zepeda , Paola Neri , Nizar J. Bahlis
Blood 130 123 -123
10
2017
High-Risk Myeloma Is Demarcated By Immunoglobulin Lambda Light Chain Translocations
Paula M Vertino , Jonathan J. Keats , Benjamin Barwick , Sagar Lonial
Blood 130 1780 -1780
1
2017
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins.
Constantine S. Mitsiades , Constantine S. Mitsiades , Robert L. Schlossman , Aviad Tsherniak
Cell Reports 34 ( 1) 108532
31
2021